Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMercia Asset Regulatory News (MERC)

Share Price Information for Mercia Asset (MERC)

Share Price is delayed by 15 minutes
Get Live Data
26.50    0.00 (0.00%)
Bid:
26.00
Ask:
27.00
Spread: 1.00 (3.846%)
Market Cap: £111.86m
MERC Live PriceLast checked at - London Stock Exchange

Intraday Mercia Asset Share Chart

PDMR Dealing

11 Apr 2019 09:41

RNS Number : 8966V
Mercia Technologies PLC
11 April 2019
 

RNS

11 April 2019

 

Mercia Technologies PLC

("Mercia", the "Group" or the "Company")

PDMR Dealing

 

Mercia Technologies PLC (AIM: MERC), the national investment group focused on the identification, creation, funding and scaling of innovative technology businesses with high growth potential from the UK regions, announces that it has received a notification of the following transaction relating to Ordinary shares of £0.00001 each in the capital of Mercia ("Ordinary Shares") by a PDMR of the Company as follows:

 

· Peter Dines, Chief Operating Officer of the Company, became beneficially interested in a further 41,000 Ordinary Shares. The Shares were bought on his behalf on 10 April 2019 at 36.0p per share.

 

Following the above transaction, Peter Dines is beneficially interested in the following number of Ordinary Shares:

 

PDMR

Number of Ordinary Shares

Percentage of issued Ordinary share capital

Peter Dines

86,551

0.03%

 

The notification below is made in accordance with the requirements of the Market Abuse Regulation.

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Peter Dines

2

Reason for the notification

a)

Position / status

Chief Operating Officer (PDMR)

b)

Initial notification / amendment

Initial

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Mercia Technologies PLC

b)

LEI

213800A1Q4CF57NECG66

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of £0.00001 each

ISIN: GB00BSL71W47

b)

 

Nature of the transaction

 

Acquisition of 41,000 Ordinary shares

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

Volume(s)

36.0p per share

41,000

 

d)

Aggregated information

- Aggregated volume

- Price

 

N/A - single transaction

e)

Date of the transaction

10 April 2019, UK

f)

Place of the transaction

AIM (AIMX)

 

For further information, please contact:

 

Mercia Technologies PLC

+44 (0)330 223 1430

Mark Payton, Chief Executive Officer

 

Martin Glanfield, Chief Financial Officer

 

www.merciatech.co.uk

 

 

 

Canaccord Genuity Limited

+44 (0)20 7523 8000

Simon Bridges, Emma Gabriel (NOMAD and Broker)

 

 

 

Buchanan

+44 (0)20 7466 5000

Chris Lane, Vicky Hayns, Stephanie Watson, Catriona Flint

 

www.buchanan.uk.com

 

 

About Mercia Technologies PLC

 

Mercia is a national investment group focused on the funding and scaling of innovative technology businesses with high growth potential from the UK regions. The Group benefits from 19 university partnerships and offices across the Midlands, the North of England and Scotland providing it with access to high quality, regional deal flow. Mercia Technologies PLC is quoted on AIM with the epic "MERC".

Mercia's 'Complete Capital Solution' initially nurtures businesses via its third-party funds and then over time Mercia can provide further funding to the most promising companies, by deploying direct investment follow-on capital from its own balance sheet. Mercia has c.£500million of assets under management and, since its IPO in December 2014, has invested over £74million across its direct investment portfolio.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHUAOWRKWASARR
Date   Source Headline
17th Nov 20177:00 amRNSNew Direct Investment in £5.0m syndicated round
14th Nov 20177:00 amRNSLife Sciences & Biosciences sector update
1st Nov 20177:00 amRNSNew Partnership with the University of Edinburgh
31st Oct 20177:00 amRNSNotice of Results
25th Oct 20177:00 amRNSAppointment of Joint Broker
5th Oct 20177:00 amRNSFurther significant fund realisation achieved
3rd Oct 20177:00 amRNSWebsite launch
20th Sep 20177:00 amRNS£3.1million syndicated investment
18th Sep 201711:05 amRNSResult of AGM
18th Sep 20177:00 amRNSAGM statement
21st Aug 20177:00 amRNS£2.0m investment into Oxford Genetics
2nd Aug 20177:00 amRNSBoard Change
25th Jul 20177:00 amRNSGrant Options & PDMR Dealings
21st Jul 20177:00 amRNSPublication of Annual Report
13th Jul 20177:00 amRNSMercia invests additional £2.0million into nDreams
3rd Jul 20177:00 amRNSPreliminary results
21st Jun 20177:00 amRNSInvestment into Impression Tech & Sector Update
6th Jun 20177:00 amRNSFurther investment into Oxford Genetics
3rd May 20177:00 amRNSNotice of Preliminary Results
22nd Feb 20177:00 amRNSTwo major contracts for Northern Powerhouse Funds
17th Feb 201712:00 pmRNSNotification of Major Interest in Shares
16th Feb 201710:43 amRNSResult of General Meeting & Completion of Placing
31st Jan 20172:40 pmRNSPlacing of new Ordinary Shares to raise c.£40.0m
26th Jan 20177:00 amRNSNotice of Mercia Annual Gala Dinner
18th Jan 20177:00 amRNSNew Direct Investment in Faradion Limited
16th Dec 20167:00 amRNSSale of Allinea Software Limited to ARM
16th Nov 20167:00 amRNS£1m invested in nDreams as part of £2m syndication
10th Nov 20167:00 amRNSHalf Year Results
28th Oct 20167:00 amRNSNotice of Results
27th Oct 20167:00 amRNSInvestment in Oxford Genetics Limited
19th Oct 20167:00 amRNSWarwick Audio Technologies strengthens Board
11th Oct 20167:00 amRNSDigital & Digital Entertainment Portfolio Update
5th Oct 20167:00 amRNSCapital Markets Event
27th Sep 20167:00 amRNSInvestment into innovative healthcare - Medherant
19th Sep 201610:36 amRNSResult of AGM
26th Aug 20167:00 amRNSDirector/PDMR Shareholdings
29th Jul 20167:00 amRNSPublication of Annual Report
28th Jul 20167:00 amRNSGrant Options & PDMR Dealings
26th Jul 20168:30 amRNSRe. Admission to AIM of Concepta PLC
21st Jul 20167:00 amRNSnDreams launches The Assembly for Oculus RIFT
7th Jul 20167:00 amRNSAcquisition, Placing & Open Offer, Change of Name
7th Jul 20167:00 amRNSFundraising & AIM Admission of Direct Investment
30th Jun 20167:00 amRNSPreliminary Results
20th Jun 20167:00 amRNSFour New University Partnerships
1st Jun 20167:00 amRNSNotice of Preliminary Results
26th May 20167:00 amRNSBoard Changes
20th May 20167:00 amRNSMercia's nDreams signs Google VR app deal
9th May 20167:00 amRNSFirst Direct Investment via Enterprise Ventures
17th Mar 20163:30 pmRNSNotification of Major Interest in Shares
17th Mar 20167:00 amRNSNew Direct Investment

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.